| NAME OF THE PROJECT | : Sitagliptin |
| PRODUCT NAME | : Sitagliptin Impurity BOC |
| CODE & CAT NO | :LP - 5910-03-005 |
| MOLECULAR FORMULA | : C21H23F6N5O3 |
| MOLECULAR WEIGHT | : 507.43 |
| CAS NO | : 486460-23-5 |
| CHEMICAL NAME | : N-[(1R)-3-[5,6-Dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-3-oxo-1-[(2,4,5-trifluorophenyl)methyl]propyl]carbamic acid 1,1-Dimethylethyl Ester |
| CAT NO | : LP - 5910-01-001 |
| CAS NO | : 486460-32-6 |
| Mol.F | : C16H15F6N5O |
| Mol.Wt. | : 407.31 |
| CAT NO | : LP - 5910-03-006 |
| CAS NO | : 936630-57-8 |
| Mol.F | : C10H10F3NO2 |
| Mol.Wt. | : 233.19 |
| CAT NO | : LP-5910-03-007 |
| CAS NO | : 823817-58-9 |
| Mol.F | : C16H15F6N5O.H3PO4 |
| Mol.Wt. | : 505.31 |
| CAT NO | : LP - 5910-03-010 |
| CAS NO | : 1345822-87-8 |
| Mol.F | : C16H16F5N5O |
| Mol.Wt. | : 389.32 |
| CAT NO | : LP - 5910-03-001 |
| CAS NO | : 2592-95-2 |
| Mol.F | : C6H5N3O |
| Mol.Wt. | : 135.12 |
| CAT NO | : LP - 5910-03-002 |
| CAS NO | : 25952-53-8 |
| Mol.F | : C8H18ClN3 |
| Mol.Wt. | : 191.7 |
| CAT NO | : LP - 5910-03-003 |
| CAS NO | : 762240-92-6 |
| Mol.F | : C6H8ClF3N4 |
| Mol.Wt. | : 228.6 |
| CAT NO | : LP - 5910-03-004 |
| CAS NO | : 486460-00-8 |
| Mol.F | : C15H18F3NO4 |
| Mol.Wt. | : 333.3 |
| CAT NO | : LP - 5910-03-005 |
| CAS NO | : 486460-23-5 |
| Mol.F | : C21H23F6N5O3 |
| Mol.Wt. | : 507.43 |
| CAT NO | : LP - 5910-03-008 |
| CAS NO | : 32897-26-0 |
| Mol.F | : C8H19N3O |
| Mol.Wt. | : 173.26 |
| CAT NO | : LP-5910-03-012 |
| CAS NO | : 486459-88-5 |
| Mol.F | : C16H16F5N5O |
| Mol.Wt. | : 389.32 |
| CAT NO | : LP-5910-03-014 |
| CAS NO | : 1253056-18-6 |
| Mol.F | : C16H12F6N4O |
| Mol.Wt. | : 390.28 |
| CAT NO | : LP-5910-03-015 |
| CAS NO | : 1675201-14-5 |
| Mol.F | : C16H12F6N4O |
| Mol.Wt. | : 390.28 |
| CAT NO | : LP-5910-03-011 |
| CAS NO | : 1345822-86-7 |
| Mol.F | : C16H16F5N5O |
| Mol.Wt. | : 389.32 |
| CAT NO | : LP-5910-03-014 |
| CAS NO | : 1253056-18-6 |
| Mol.F | : C16H12F6N4O |
| Mol.Wt. | : 390.28 |
CATEGORY : Sitagliptin
TOTAL PRODUCTS : 15
FILTER BY : API
Lavybens pharma's competitive advanced manufacturing facilities, R & D capabilities, extensive domestic network in Indian Pharma market and International.
Copyrights © Lavybens Pharma All rights Reserved
